About the Director
Harold Varmus, M.D., co-recipient of a Nobel Prize for studies of the genetic basis of cancer, began his tenure as NCI Director on July 12, 2010. He previously served as President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center (MSKCC) and as Director of the National Institutes of Health (NIH). More >>
NCI Director's Report at AACR 2013 Meeting
Harold Varmus, M.D. presents the NCI Director's Report at the Annual Meeting of the American Association for Cancer Research, April 2013.
View Webcast >>
What's New
Message to Grantees About NCI Funding and Grant Support for FY2013
May, 2013
Harold Varmus sent an email to all NCI grantees informing them of reductions to NCI’s budget for fiscal year 2013. The reductions, due in large part to sequestration, are spread across NCI’s portfolio to protect NCI’s ability to issue new and competing research project grants.
Harold Varmus Requests Input on NCI Cloud Initiative
April, 2013
Biomedical researchers are asked for their input on scientific questions that should guide the process of developing computational infrastructure to analyze high volume data sets from genomics research.
Message to Grantees About NCI Funding and Grant Support For FY2013
March 7, 2013
Harold Varmus sent an e-mail to all NCI grantees about the impact of sequestration on NCI funding and grant support for fiscal year 2013.
Interview on NPR's Diane Rehm Show
January 9, 2013
Harold Varmus discusses the latest cancer statistics and the challenges of funding research
Written Testimony on Fiscal Year 2013 Budget Request (Senate)
March 28, 2012
Subcommittee on Labor, Health and Human Services, Education, and Related Agencies; Committee on Appropriations; United States Senate
Provocative Questions in Cancer Research - Nature
January 19, 2012
Harold Varmus and Ed Harlow discuss the NCI's recent RFA soliciting grant applications that seek to answer a set of questions proposed by the scientific community about unsolved problems in cancer research.
Featured NCI Initiatives
Provocative
Questions
Clinical Trials Transformation
The Cancer Genome Atlas
